Ayala Pharmaceuticals, Inc.
SEC Filing List
ADXS CIK: 0001100397
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | M2 Compliance FA /fa | 04/16/2025 | |||
| 15-12G | Notice of termination of registration of... | 1100397 | BINGHAM MCCUTCHEN LLP /fa | 05/09/2024 | |
| 10-K/A | Amendment to annual report pursuant to S... | Ayala Pharmaceuticals, Inc. | M2 COMPLIANCE LLC /fa | 04/26/2024 | |
| 8-K/A | Amendment to Current report filing | Ayala Pharmaceuticals, Inc. | BINGHAM MCCUTCHEN LLP /fa | 04/19/2024 | |
| 10-K | Annual report pursuant to Section 13 and... | Ayala Pharmaceuticals, Inc. | M2 COMPLIANCE LLC /fa | 04/16/2024 | |
| S-8 POS | Post-effective amendment to a S-8 regist... | Ayala Pharmaceuticals, Inc. | BINGHAM MCCUTCHEN LLP /fa | 04/15/2024 | |
| S-8 POS | Post-effective amendment to a S-8 regist... | Ayala Pharmaceuticals, Inc. | BINGHAM MCCUTCHEN LLP /fa | 04/15/2024 | |
| S-8 POS | Post-effective amendment to a S-8 regist... | Ayala Pharmaceuticals, Inc. | BINGHAM MCCUTCHEN LLP /fa | 04/15/2024 | |
| S-8 POS | Post-effective amendment to a S-8 regist... | Ayala Pharmaceuticals, Inc. | BINGHAM MCCUTCHEN LLP /fa | 04/15/2024 | |
| S-8 POS | Post-effective amendment to a S-8 regist... | Ayala Pharmaceuticals, Inc. | BINGHAM MCCUTCHEN LLP /fa | 04/15/2024 | |
| No record found. | |||||
| Load More | |||||
